US 8618058
Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity
granted A61KA61K31/337A61K31/555
Quick answer
US patent 8618058 (Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity) held by Soricimed Biopharma Inc. expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Soricimed Biopharma Inc.
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/337, A61K31/555, A61K38/00, A61K38/1761